13:55 IST
BSE
Management Change
Bharat Parenterals Management Change
Bharat Parenterals Limited has re-appointed Mr. Hemang Jayendrabhai Shah as Executive Director for a 5-year term effective July 2, 2026.
Bharat Parenterals Ltd
- Share price
- ₹1,880.80
- Market cap
- ₹1,296 Cr
- Revenue (annual)
- ₹345.4 Cr
- Net profit (annual)
- ₹-8.19 Cr
- P/E (TTM)
- -84.2×Sector 47.4×
- Promoter holding
- 67.20%+0.03% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Management Change 2Board Meeting Date 2Annual General Meeting 2Other Announcement 1Financial Results 1Earnings Call 1Dividend 1Capacity Expansion 1Annual Report 1
Time
2 announcements with these filters
17:57 IST
BSE
Management Change
Bharat Parenterals Management Change
Bharat Parenterals Ltd re-appointed Mr. Hemang Shah as Executive Director for a five-year term. The appointment is subject to shareholder approval at the ensuing AGM.